BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2958950)

  • 1. Failure of ipratropium bromide to modify the diurnal variation of asthma in asthmatic children.
    Sly PD; Landau LI; Olinsky A
    Thorax; 1987 May; 42(5):357-60. PubMed ID: 2958950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.
    Britton J; Hanley SP; Garrett HV; Hadfield JW; Tattersfield AE
    Thorax; 1988 Apr; 43(4):300-5. PubMed ID: 2970125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cessation of short-term therapy with ipratropium bromide on lung function and airway responsiveness.
    Wilding PJ; Clark MM; Pavord ID; Parker D; Bennett JA; Tattersfield AE
    Eur Respir J; 1996 Aug; 9(8):1627-31. PubMed ID: 8866584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of oxitropium bromide and ipratropium bromide in asthma.
    Peel ET; Anderson G; Cheong B; Broderick N
    Eur J Respir Dis; 1984 Feb; 65(2):106-8. PubMed ID: 6230249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilator effects of clemastine, ipratropium, bromide, and salbutamol in preschool children with asthma.
    Groggins RC; Milner AD; Stokes GM
    Arch Dis Child; 1981 May; 56(5):342-4. PubMed ID: 6455096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ipratropium bromide in children with asthma.
    Mann NP; Hiller EJ
    Thorax; 1982 Jan; 37(1):72-4. PubMed ID: 6461943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis.
    Higgins BG; Powell RM; Cooper S; Tattersfield AE
    Eur Respir J; 1991 Apr; 4(4):415-20. PubMed ID: 1830277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine-induced bronchial response after administration of placebo, salbutamol and a combination of a beta-2-adrenergic drug (fenoterol) with an anticholinergic agent (ipratropium bromide) in asymptomatic asthma patients.
    Fontana G; Mugnai M; Cresci F; Panuccio P
    Respiration; 1986; 50 Suppl 2():201-5. PubMed ID: 2951806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ipratropium bromide in patients with nocturnal asthma.
    Cox ID; Hughes DT; McDonnell KA
    Postgrad Med J; 1984 Aug; 60(706):526-8. PubMed ID: 6236436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ipratropium bromide in acute asthma.
    Ward MJ; Fentem PH; Smith WH; Davies D
    Br Med J (Clin Res Ed); 1981 Feb; 282(6264):598-600. PubMed ID: 6451257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salbutamol and ipratropium in acute asthma.
    Rayner RJ; Cartlidge PH; Upton CJ
    Arch Dis Child; 1987 Aug; 62(8):840-1. PubMed ID: 2959208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ipratropium bromide (Atrovent) in childhood asthma: a cumulative dose-response study.
    Friberg S; Graff-Lonnevig V
    Ann Allergy; 1989 Feb; 62(2):131-4. PubMed ID: 2521989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic drugs in airways obstruction.
    Anderson G
    Postgrad Med J; 1983; 59 Suppl 3():64-5. PubMed ID: 6227880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of asthma bronchiale with a combination of ipratropium bromide and fenoterol.
    Sahlström K; Alanko K; Härkönen R
    Respiration; 1986; 50 Suppl 2():302-9. PubMed ID: 2951826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebulised ipratropium bromide in wheezy infants and young children.
    Stokes GM; Milner AD; Hodges IG; Henry RL
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():494-8. PubMed ID: 6225670
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term effect of ipratropium bromide and fenoterol on the bronchial hyperresponsiveness to histamine in children with asthma.
    Raes M; Mulder P; Kerrebijn KF
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):874-9. PubMed ID: 2532229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salbutamol and ipratropium bromide solution in the treatment of bronchospasm in asthmatic children.
    Boner AL; De Stefano G; Niero E; Vallone G; Gaburro D
    Ann Allergy; 1987 Jan; 58(1):54-8. PubMed ID: 2948430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of four weeks' high dose ipratropium bromide treatment on lung mucociliary clearance.
    Taylor RG; Pavia D; Agnew JE; Lopez-Vidriero MT; Newman SP; Lennard-Jones T; Clarke SW
    Thorax; 1986 Apr; 41(4):295-300. PubMed ID: 2943050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.
    Thiessen B; Pedersen OF
    Respiration; 1982; 43(4):304-16. PubMed ID: 6213991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does nifedipine affect the diurnal variation of asthma in children?
    Sly PD; Olinsky A; Landau LI
    Pediatr Pulmonol; 1986; 2(4):206-10. PubMed ID: 3532009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.